|
Market Closed -
Euronext Paris
09:25:00 20/08/2026 pm IST
|
Pre-market 11:07:32 am | |||
| 77.79 EUR | -0.98% |
|
77.60 | -0.25% |
| 20/08 | Pharma sector doubles down on AI amid hopes of slashing costs, timelines | RE |
| 20/08 | Cancer vaccines finally garner the spotlight |  |
| Market Cap | 9.32TCr 11TCr 8.7TCr 7.98TCr 15TCr 10,41500Cr 15TCr 1,03200Cr 40TCr 5,22000Cr 41TCr 40TCr 17,28100Cr | P/E 2026 * |
12.4x | P/E 2027 * | 10.8x |
|---|---|---|---|---|---|
| Enterprise Value | 10TCr 12TCr 9.76TCr 8.96TCr 17TCr 11,69100Cr 17TCr 1,15800Cr 45TCr 5,85900Cr 46TCr 45TCr 19,39700Cr | EV / Sales 2026 * |
2.2x | EV / Sales 2027 * | 2x |
| Free-Float |
88.34% | Yield 2026 * |
5.47% | Yield 2027 * | 5.78% |
Last Transcript: Sanofi
| 1 day | -0.98% | ||
| 1 week | +1.78% | ||
| Current month | +4.46% | ||
| 1 month | +1.14% | ||
| 3 months | +1.46% | ||
| 6 months | -2.25% | ||
| Current year | -5.96% |
| 1 week | 75.49 |  | 78.94 |
| 1 month | 72.07 | | 80.18 |
| Current year | 71.25 | | 84.97 |
| 1 year | 71.25 | | 91.15 |
| 3 years | 71.25 | | 110.88 |
| 5 years | 71.25 | | 110.88 |
| 10 years | 62.88 | | 110.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 01/05/2026 | |
| Director of Finance/CFO | 64 | 01/04/2024 | |
Houman Ashrafian
CTO | Chief Tech/Sci/R&D Officer | 51 | 11/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 60 | 30/04/2019 | |
Rachel Duan
BRD | Director/Board Member | 57 | 28/04/2020 |
Lise Kingo
BRD | Director/Board Member | 65 | 28/04/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06/07/26 | Others | Executive/Senior Manager | 55,000 | 0.0045% | ||
| 15/11/25 | Buy | Director | 207 | 0.0000% | ||
| 29/07/25 | Buy | Director | 6 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.98% | +1.78% | -10.62% | -20.62% | 11TCr | |
| -2.81% | +2.93% | +76.40% | +127.73% | 1,14100Cr | |
| -2.21% | +2.02% | +49.50% | +55.01% | 66TCr | |
| -1.56% | +4.39% | +25.19% | +74.39% | 47TCr | |
| +1.20% | +2.62% | +41.69% | +45.78% | 37TCr | |
| -0.61% | +2.10% | +23.43% | +41.34% | 30TCr | |
| +0.32% | +3.25% | +0.94% | +13.42% | 25TCr | |
| -1.95% | +3.80% | +46.31% | +65.66% | 24TCr | |
| -1.10% | -0.70% | -14.31% | -52.66% | 21TCr | |
| -2.82% | +3.84% | +20.81% | +89.04% | 18TCr | |
| Average | -1.25% | +2.83% | +25.93% | +43.91% | 39.31TCr | |
| Weighted average by Cap. | -1.62% | +3.12% | +41.97% | +68.30% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.76TCr 5.56TCr 4.44TCr 4.07TCr 7.66TCr 5,31900Cr 7.81TCr 53TCr 21TCr 2,66600Cr 21TCr 20TCr 8,82500Cr | 5.07TCr 5.92TCr 4.73TCr 4.34TCr 8.16TCr 5,66600Cr 8.32TCr 56TCr 22TCr 2,84000Cr 22TCr 22TCr 9,40200Cr |
| Net income | 794.11Cr 927.48Cr 740.92Cr 679.86Cr 1.28TCr 89TCr 1.3TCr 8.79TCr 3.43TCr 44TCr 3.48TCr 3.41TCr 1,47200Cr | 926.69Cr 1.08TCr 864.62Cr 793.37Cr 1.49TCr 1,03600Cr 1.52TCr 10TCr 4TCr 52TCr 4.06TCr 3.98TCr 1,71800Cr |
| Net Debt | 1.14TCr 1.33TCr 1.07TCr 977.29Cr 1.84TCr 1,27600Cr 1.87TCr 13TCr 4.93TCr 64TCr 5.01TCr 4.9TCr 2,11700Cr | 823.26Cr 961.52Cr 768.11Cr 704.82Cr 1.32TCr 92TCr 1.35TCr 9.11TCr 3.55TCr 46TCr 3.61TCr 3.53TCr 1,52600Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/26/20 | €77.79 | -0.98% | 14,06,571 |
| 19/26/19 | €78.56 | +1.15% | 17,87,672 |
| 18/26/18 | €77.67 | +1.32% | 19,71,698 |
| 17/26/17 | €76.66 | +1.51% | 10,83,029 |
| 14/26/14 | €75.52 | -1.19% | 14,28,310 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SAN Stock
Select your edition
All financial news and data tailored to specific country editions
